NO174971C - Fremgangsmåter for bestemmelse av polypetider som er komplementære til peptider eller proteiner som har en aminosyresekvens eller en nukleotidkodende sekvens som er minst delvis kjent - Google Patents

Fremgangsmåter for bestemmelse av polypetider som er komplementære til peptider eller proteiner som har en aminosyresekvens eller en nukleotidkodende sekvens som er minst delvis kjent

Info

Publication number
NO174971C
NO174971C NO864369A NO864369A NO174971C NO 174971 C NO174971 C NO 174971C NO 864369 A NO864369 A NO 864369A NO 864369 A NO864369 A NO 864369A NO 174971 C NO174971 C NO 174971C
Authority
NO
Norway
Prior art keywords
peptides
proteins
amino acid
methods
acid sequence
Prior art date
Application number
NO864369A
Other languages
English (en)
Norwegian (no)
Other versions
NO864369D0 (no
NO174971B (no
NO864369L (no
Inventor
J Edwin Blalock
Kenneth L Bost
Eric M Smith
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/708,001 external-priority patent/US4863857A/en
Application filed by Univ Texas filed Critical Univ Texas
Publication of NO864369D0 publication Critical patent/NO864369D0/no
Publication of NO864369L publication Critical patent/NO864369L/no
Publication of NO174971B publication Critical patent/NO174971B/no
Publication of NO174971C publication Critical patent/NO174971C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
NO864369A 1985-03-01 1986-10-31 Fremgangsmåter for bestemmelse av polypetider som er komplementære til peptider eller proteiner som har en aminosyresekvens eller en nukleotidkodende sekvens som er minst delvis kjent NO174971C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/708,001 US4863857A (en) 1985-03-01 1985-03-01 Polypeptide complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
US06/829,709 US5077195A (en) 1985-03-01 1986-02-19 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
PCT/US1986/000353 WO1986005208A1 (fr) 1985-03-01 1986-02-24 Polypeptides complementaires de peptides ou de proteines dont la sequence d'acides amines ou la sequence de codage des nucleotides sont au moins partiellement connues et leurs procedes de conception

Publications (4)

Publication Number Publication Date
NO864369D0 NO864369D0 (no) 1986-10-31
NO864369L NO864369L (no) 1987-01-02
NO174971B NO174971B (no) 1994-05-02
NO174971C true NO174971C (no) 1994-08-10

Family

ID=27108003

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864369A NO174971C (no) 1985-03-01 1986-10-31 Fremgangsmåter for bestemmelse av polypetider som er komplementære til peptider eller proteiner som har en aminosyresekvens eller en nukleotidkodende sekvens som er minst delvis kjent

Country Status (18)

Country Link
US (2) US5077195A (fr)
EP (2) EP0214232B1 (fr)
JP (1) JPH07215999A (fr)
KR (1) KR920002315B1 (fr)
AT (2) ATE63138T1 (fr)
AU (1) AU592781B2 (fr)
BR (1) BR8606615A (fr)
CA (1) CA1339606C (fr)
DE (2) DE3688333T2 (fr)
DK (1) DK521386A (fr)
ES (3) ES8705919A1 (fr)
FI (1) FI90255C (fr)
GR (1) GR860576B (fr)
IE (1) IE58837B1 (fr)
IL (1) IL96043A0 (fr)
NO (1) NO174971C (fr)
PT (1) PT82132B (fr)
WO (1) WO1986005208A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0779717B2 (ja) * 1984-10-29 1995-08-30 マイクロジエニツクス コ−ポレ−シヨン タンパク質結合酵素相補性検定に関する方法
DE3527568A1 (de) * 1985-08-01 1987-02-05 Bissendorf Peptide Gmbh Synthetische peptidrezeptoren, verfahren zur herstellung und verwendung derselben
CA1297003C (fr) * 1985-09-20 1992-03-10 Jack H. Nunberg Composition et methode pour traiter les animaux
WO1987005029A2 (fr) * 1986-02-19 1987-08-27 Triton Biosciences Inc Peptides affectant la regulation de la tension arterielle
US4772684A (en) * 1987-01-20 1988-09-20 Triton Biosciences, Inc. Peptides affecting blood pressure regulation
JPH02104595A (ja) * 1988-03-04 1990-04-17 Univ Alabama 非ペプチドのペプチド相当物及びそのデザイン方法
ATE187738T1 (de) * 1989-07-31 2000-01-15 Tecnogen Scpa Verfahren zur identifizierung und herstellung von bindungsstellen aufeinanderwirkender proteine
US5324512A (en) * 1990-12-26 1994-06-28 The Population Council [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses
JPH05262788A (ja) * 1991-09-03 1993-10-12 Hitachi Chem Co Ltd ペプチド類、その設計方法及び製造方法並びに受容体上の生理活性ペプチドの結合部位の決定方法
US5620675A (en) * 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
JP3923515B2 (ja) * 1993-10-07 2007-06-06 倉敷紡績株式会社 エンドセリン活性抑制剤
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
IL115177A0 (en) * 1994-09-16 1995-12-31 Immunomedics Inc Phosphorus-32 labeling of antibodies for cancer therapy
US5523208A (en) * 1994-11-30 1996-06-04 The Board Of Trustees Of The University Of Kentucky Method to discover genetic coding regions for complementary interacting proteins by scanning DNA sequence data banks
DE69627333T2 (de) * 1995-06-26 2004-02-12 PerSeptive Biosystems, Inc., Framingham Automatisierte, kontinuierliche mehrdimensionale hochgeschwindigkeitsmolekularselektion und -analyse
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
DK1039931T3 (da) * 1997-12-01 2005-08-08 Fang Fang Multivalente rekombinante antistoffer til at behandle HRV infektioner
DE19805334A1 (de) * 1998-02-11 1999-08-12 Otogene Biotechnologische Fors Verfahren zur Entwicklung eines pharmazeutischen Wirkstoffes
WO1999055911A1 (fr) * 1998-04-24 1999-11-04 Fang Fang Identification de ligands peptidiques de proteines cibles par la technique des banques complementaires de cibles tclt
US20030035798A1 (en) * 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
ES2316356T3 (es) * 1999-03-09 2009-04-16 Fornix Biosciences N.V. Peptidos sinteticos complementarios y sus utilizaciones oftalmologicas.
GB2356401A (en) 1999-11-19 2001-05-23 Proteom Ltd Method for manipulating protein or DNA sequence data
GB9929464D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligande generated from the human genome
GB9929469D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from plant genomes
GB9929466D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from microbial genome sequences
AU2001294822A1 (en) * 2000-09-26 2002-04-08 Geneformatics, Inc. Methods for determining aproximations of three dimensional polypeptide structure
GB0025251D0 (en) * 2000-10-14 2000-11-29 Proteom Ltd Antisense peptides to Fc receptors and their uses
JP2004525627A (ja) * 2001-02-20 2004-08-26 ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド モノクローナル抗体の迅速な産生
CA2898314A1 (fr) * 2001-07-19 2003-07-31 Perian Therapeutics, Inc. Proteines multimeres et methodes de production et d'utilisation de ces proteines
US8227583B2 (en) * 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
RU2519210C2 (ru) * 2007-06-14 2014-06-10 Дзе Борд Оф Риджентс Фор Оклахома Стейт Юниверсити Вакцины, содержащие генетические варианты парвовируса собак
WO2019046634A1 (fr) * 2017-08-30 2019-03-07 Peption, LLC Procédé de génération de peptides interagissants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes

Also Published As

Publication number Publication date
PT82132A (en) 1986-04-01
DK521386A (da) 1986-12-29
EP0332225B1 (fr) 1993-04-21
IL96043A0 (en) 1991-07-18
EP0332225A3 (en) 1989-09-27
DE3688333D1 (de) 1993-05-27
ES557189A0 (es) 1987-11-01
BR8606615A (pt) 1987-08-11
CA1339606C (fr) 1997-12-30
ES8800267A1 (es) 1987-11-01
ES8705919A1 (es) 1987-05-16
ATE63138T1 (de) 1991-05-15
GR860576B (en) 1986-07-01
NO864369D0 (no) 1986-10-31
ATE88572T1 (de) 1993-05-15
FI90255B (fi) 1993-09-30
DE3688333T2 (de) 1993-10-28
ES557188A0 (es) 1987-11-01
NO174971B (no) 1994-05-02
AU592781B2 (en) 1990-01-25
DK521386D0 (da) 1986-10-31
US5077195A (en) 1991-12-31
FI864427A (fi) 1986-10-30
AU5510286A (en) 1986-09-24
IE860527L (en) 1986-09-01
US5212072A (en) 1993-05-18
NO864369L (no) 1987-01-02
EP0332225A2 (fr) 1989-09-13
PT82132B (pt) 1989-05-31
DE3679017D1 (de) 1991-06-06
IE58837B1 (en) 1993-11-17
EP0214232A1 (fr) 1987-03-18
EP0214232B1 (fr) 1991-05-02
ES8800266A1 (es) 1987-11-01
WO1986005208A1 (fr) 1986-09-12
ES552534A0 (es) 1987-05-16
JPH07215999A (ja) 1995-08-15
FI864427A0 (fi) 1986-10-30
KR870700100A (ko) 1987-02-28
FI90255C (fi) 1994-01-10
KR920002315B1 (ko) 1992-03-21

Similar Documents

Publication Publication Date Title
NO174971C (no) Fremgangsmåter for bestemmelse av polypetider som er komplementære til peptider eller proteiner som har en aminosyresekvens eller en nukleotidkodende sekvens som er minst delvis kjent
DE3587814D1 (de) Verfahren zum erhalten von dns, rns, peptiden, polypeptiden oder proteinen durch dns-rekombinant-verfahren.
DK532284A (da) Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser
Benjamini et al. Immunochemical studies on the tobacco mosaic virus protein. I. The immunological relationship of the tryptic peptides of tobacco mosaic virus protein to the whole protein
LU91014I2 (fr) Kogentate (Octocog alfa) dans toutes ses formes couvertes par le brevet de base
DE3856560D1 (de) Dem menschlichen gewebefaktor ähnliche dns-segmente, polypeptide und antikörper
NO975435L (no) Modifiserte/kimeriske proteiner samt anvendelse derav
ATE189684T1 (de) Rekombinante polypeptide und peptide, dafür kodierende nukleinsäuren und ihre verwendung in der tuberkulose-diagnose
DK175843B1 (da) Polypeptider af overfladeaktive alvelolarproteiner (ASP), farmaceutisk sammensætning indeholdende polypeptidet, DNA-ekspressionssystem der koder for polypeptidet, samt fremgangsmåde til fremstilling af polypeptider med ASP-aktivitet
JPS646219A (en) Peptide having promoting action on activation of protein c by thrombin
ATE50458T1 (de) Bestimmung von fibrin mit fibrin-spezifischen antikoerpern.
ATE197155T1 (de) Stannius- körperchen -protein, stanniocalcin
ATE301712T1 (de) Z2-19a, ein menschliches homolog von dem protein 2-19
Schalekamp et al. Recombination of embryonic haemoglobin chains during the development of the chick
Roholt et al. A light chain tyrosyl sequence in the antibody site of a rabbit anti-p-azobenzoate antibody
Carrel et al. Studies on sheep anti-human IgG antibodies and their sub-units